Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of acute myeloid leukemia cells

Molecular Medicine Reports

Volumn 12, Issue 5, 2015, Pages 6861-6866

  Li, Na ^a   Jia, Xiuhong ^a   Wang, Jianyong ^a   Li, Youjie ^a   Xie, Shuyang ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell growth; Chemosensitivity; Homeobox A5; Leukemia; Small hairpin RNA

Indexed keywords

CASPASE 3; CYTARABINE; MESSENGER RNA; SHORT HAIRPIN RNA; SURVIVIN; ANTINEOPLASTIC ANTIMETABOLITE; HOMEODOMAIN PROTEIN; HOXA5 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL COUNTING; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HOMEOBOX; HOMEOBOX A5; HUMAN; HUMAN CELL; INVESTIGATIVE PROCEDURES; LEUKEMIA CELL; PROTEIN EXPRESSION; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; U937 CELL LINE; WESTERN BLOTTING; DRUG RESISTANCE; GENETICS; LEUKEMIA, MYELOID, ACUTE; PATHOLOGY; RNA INTERFERENCE;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL PROLIFERATION; CYTARABINE; DRUG RESISTANCE, NEOPLASM; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; RNA INTERFERENCE; RNA, SMALL INTERFERING; U937 CELLS;

EID: 84943604120     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4331     Document Type: Article

References (32)

1. Passegue E, Jamieson CH, Ailles LE and Weissman IL: Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 100 (Suppl 1):11842-11849, 2003.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics. 2010. CA Cancer J Clin 60: 277-300, 2010.
3. Estey E and Dohner H: Acute myeloid leukaemia. Lancet 368: 1894-1907, 2006.
4. Bali P, George P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Scuto A, Annavarapu S, Fiskus W, et al: Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3. Clin Cancer Res 10: 4991-4997, 2004.
5. Christiansen DH, Andersen MK, Desta F and Pedersen-Bjergaard J: Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 19: 2232-2240, 2005.
6. Plass C, Oakes C, Blum W and Marcucci G: Epigenetics in acute myeloid leukemia. Semin Oncol 35: 378-387, 2008.
7. Yao K, Xing H, Yang W, Liao A, Wu B, Li Y, Zhang R and Liu Z. Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells. Tumour Biol 35: 8023-8031, 2014.
8. Cillo C, Cantile M, Faiella A and Boncinelli E: Homeobox genes in normal and malignant cells. J Cell Physiol 188: 161-169, 2001.
9. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, Dohner H and Pollack JR: Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350: 1605-1616, 2004.
10. Grubach L, Juhl-Christensen C, Rethmeier A, Olesen LH, Aggerholm A, Hokland P and Ostergaard M: Gene expression profiling of Polycomb: Hox and Meis genes in patients with acute myeloid leukaemia. Eur J Haematol 81: 112-122, 2008.
11. Thorsteinsdottir U, Sauvageau G and Humphries RK. Hox homeobox genes as regulators of normal and leukemic hematopoiesis. Hematol Oncol Clin North Am 11: 1221-1237, 1997.
12. Crooks GM, Fuller J, Petersen D, Izadi P, Malik P, Pattengale PK, Kohn DB and Gasson JC: Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood 94: 519-528, 1999.
13. Lawrence HJ and Largman C: Homeobox genes in normal hematopoiesis and leukemia. Blood 80: 2445-2453, 1992.
14. Celetti A, Barba P, Cillo C, Rotoli B, Boncinelli E and Magli MC. Characteristic patterns of HOX gene expression in different types of human leukemia. Int J Cancer 237-244, 1993.
15. Drabkin HA, Parsy C, Ferguson K, Guilhot F, Lacotte L, Roy L, Zeng C, Baron A, Hunger SP, Varella-Garcia M, et al: Quantitative HOX expression in chromosomally defined subsets of acute myelogenousleukemia. Leukemia 16: 186-195, 2002.
16. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
17. Shah N and Sukumar S: The hox genes and their roles in oncogenesis. Nat Rev Cancer 10: 361-371, 2010.
18. Graham A, Papalopulu N and Krumlauf R: The murine and drosophila homeobox gene complexes have common features of organization and expression. Cell 57: 367-378, 1989.
19. Waltregny D, Alami Y, Clausse N, de Leval J and Castronovo V: Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 50: 162-169, 2002.
20. Makiyama K, Hamada J, Takada M, Murakawa K, Takahashi Y, Tada M, Tamoto E, Shindo G, Matsunaga A, Teramoto K, et al: Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep 13: 673-679, 2005.
21. Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S and Moriuchi T: Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep 15: 797-802, 2006.
22. Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ, Humphries K and Sauvageau G: Overexpression of the myeloid leukemia-associated hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99: 121-129, 2002.
23. Bach C, Buhl S, Mueller D, Garcia-Cuellar MP, Maethner E and Slany RK: Leukemogenic transformation by HOXA cluster genes. Blood 115: 2910-2918, 2010.
24. Mulgrew NM, Kettyle LM, Ramsey JM, Cull S, Smyth LJ, Mervyn DM, Bijl JJ and Thompson A: c-Met inhibition in a HOXA9/Meis1 model of CN-AML. Dev Dyn 243: 172-181, 2014.
25. Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L and Zhang Y: Leukaemic transformation by CALM-AF10 involves upregulation of hoxa5 by hDOT1 L. Nat Cell Biol 8: 1017-1024, 2006.
26. Quentmeier H, Dirks WG, Macleod RA, Reinhardt J, Zaborski M and Drexler HG: Expression of HOX genes in acute leukemia cell lines with and without MLL translocations. Leuk Lymphoma 45: 567-574, 2004.
27. Deveraux QL and Reed JC: IAP family proteins-suppressors of apoptosis. Gen Dev 13: 239-252, 1999.
28. Karami H, Baradaran B, Esfahani A, Estiar MA, Naghavi-Behzad M, Sakhinia M and Sakhinia E: siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Asian Pac J Cancer Prev 14: 7719-7724, 2013.
29. Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907, 2004.
30. Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S and Cerni C: Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22: 4266-4280, 2003.
31. Yamanaka K, Nakata M, Kaneko N, Fushiki H, Kita A, Nakahara T, Koutoku H and Sasamata M: YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer. Int J Oncol 39: 569-575, 2011.
32. Blanc-Brude OP, Mesri M, Wall NR, Plescia J, Dohi T and Altieri DC: Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 9: 2683-2692, 2003.